# The Role of Orexin in Human Panic Disorder

> **NCT02593682** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 3 (actual)

## Conditions studied

- Panic Disorder

## Interventions

- **DRUG:** suvorexant
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02593682
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593682, "The Role of Orexin in Human Panic Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02593682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*